ProCE Banner Series

MRD Testing in NSCLC to Personalize Patient Care

It is critical to determine risk of recurrence in NSCLC to personalize patient care. MRD testing has emerged as a valuable tool to stratify by patient risk, detect recurrences earlier than standard imaging, and monitor for treatment response.

Join to learn about the clinical utility of Signatera, the most widely utilized MRD assay.

Key Takeaways

  • Learn how Signatera MRD testing aids in clinical decision making
  • Which patients are at highest risk of recurrence, and may benefit from additional treatment?
  • Can you identify recurrence earlier than standard imaging techniques, and is this valuable?
  • Which patients are not responding to systemic treatment, and may benefit from early escalation or switching of treatment regimens?

All Events

MRD Testing in NSCLC to Personalize Patient Care

Upcoming Events

February

19

2025

12:15 PM - 12:45 PM Eastern Time (ET)

Virtual